Robert Gillespie, MD
Pediatric Nephrology · Fort Worth, TXNPI 1912043738
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Amgen at 37.0% of the total. Reporting peaked in 2020 at $4,110 and has fallen 88.5% since, to $472 in 2025. Among pediatric nephrology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $267.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Mallinckrodt Enterprises LLC$3K
- Travere Therapeutics, Inc.$2K
- Sanofi$1K
- AstraZeneca$352
- Takeda Pharmaceuticals U.S.A., Inc.$130
- plus $359 from 5 others
Across 22 payments — averaging $2025.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aurinia Pharma U.S., Inc.$33K
- Sanofi US Services Inc.$11K
What the payments were for
- Consulting fees$2,65025%
- Speaking & faculty fees$4,11038%
- Travel & lodging$2,05819%
- Food & beverage$1,80917%
- Education$901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $3,960 |
| Mallinckrodt Enterprises LLC | 4 | $2,735 |
| Travere Therapeutics, Inc. | 12 | $1,743 |
| Sanofi | 12 | $1,438 |
| AstraZeneca | 3 | $352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $130 |
| Merck | 1 | $117 |
| BTG International Inc. | 1 | $90 |
| Kyowa Kirin, Inc. | 1 | $90 |
| Novo Nordisk Health Care AG | 1 | $45 |
| Coloplast | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCYSBI$3,960
- ACTHAR$2,607
- NO PRODUCT DISCUSSED$879
- ULTOMIRIS$325
- FABRAZYME$258
- PREVYMIS$117
- LIVTENCITY$109
How this compares
$10,717 in reported general payments places this provider in the 90th percentile of 61 pediatric nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProcysbiCysteamine Bitartrate | 12 | $691,637 |
| CystadropsCysteamine Hcl | 13 | $119,816 |
| Tacrolimus | 14 | $1,116 |
| Mycophenolate Mofetil | 12 | $781 |
| Prednisone | 23 | $246 |
| Labetalol Hcl | 15 | $143 |
| Cyproheptadine Hcl | 11 | $44 |
| Amlodipine Besylate | 17 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProcysbi | $3,960 | $691,63712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 61 pediatric nephrology providers in Texas.
Other pediatric nephrology in Fort Worth
- Randa RazzoukFort Worth$343
- Ketan PatelFort Worth$142
- Celina CepedaFort Worth$48
- Badreldin BedriFort Worth$18
- Amy BeckerCorpus Christi$77K
- Mini MichaelHouston$25K
- Rita SwinfordHouston$25K
- Ewa ElenbergHouston$16K
- Melissa CadnapaphornchaiSan Antonio$10K
- Samhar Al AkashCorpus Christi$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.